Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SensoLyte® 490 HCV Protease Assay Kit

FRET Reactivity: Hepatitis C Virus (HCV) Fluorometric
Catalog No. ABIN1882472
  • Target See all Hepatitis C Virus (HCV) products
    Hepatitis C Virus (HCV)
    Reactivity
    • 2
    • 1
    Hepatitis C Virus (HCV)
    Detection Method
    Fluorometric
    Application
    Fluorescence Resonance Energy Transfer Microscopy (FRET)
    Brand
    SensoLyte®
    Characteristics
    The SensoLyte® 490 HCV Protease Assay Kit uses an optimized FRET peptide substrate for the continuous measurement of HCV NS3/4a activity. This FRET substrate is cleaved specifically by HCV NS3/4a protease thereby liberating the C-terminal peptide-fluorophore fragment from the proximity quenching effect of the dark quencher, resulting in a more than 10-fold increase in fluorescence. This assay can detect HCV NS3/4a protease activity at 1 pmole.
  • Comment

    FRET-based Assay Kit

    Restrictions
    For Research Use only
  • Handling Advice
    Protect Components A and B from light.
    Storage
    -20 °C
    Storage Comment
    Store all kit components at -20 °C. Components C and D can be stored at room temperature for convenience.
  • Park, Park, Chong: "2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity." in: Bioorganic & medicinal chemistry letters, Vol. 21, Issue 11, pp. 3202-5, (2011) (PubMed).

    Peng, Schaefer, Maloof, Skaff, Berical, Belon, Heck, Lin, Frick, Allen, Miziorko, Schreiber, Chung: "Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase." in: The Journal of infectious diseases, Vol. 204, Issue 4, pp. 609-16, (2011) (PubMed).

    Yon, Viswanathan, Rossignol, Korba: "Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells." in: Antiviral research, Vol. 91, Issue 3, pp. 233-40, (2011) (PubMed).

    Frick, Ginzburg, Lam: "A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities." in: Methods in molecular biology (Clifton, N.J.), Vol. 587, pp. 223-33, (2010) (PubMed).

  • Target
    Hepatitis C Virus (HCV)
    Abstract
    HCV Products
    Target Type
    Virus
    Background
    HCV protease is identified as an important drug-screening target.
You are here:
Support